SEP 1, 2026 · JOURNAL ARTICLE
551. Esketamine in neuropsychiatric long COVID: a retrospective analysis
The International Journal of Neuropsychopharmacology
Retrospective analysis of 15 patients treated off-label with esketamine in routine clinical care, without control group, prospective protocol, or quantified outcome measures—early-phase evidence suggesting feasibility and benefit that requires controlled trials for confirmation.
Reported
Sample size15